Successful Formulation Development for Biologics Using a Unique Biophysical Prediction and Screening Platform

In this article, Pawel Stanczak, Director of Formulation Development at Tanvex CDMO, explores the critical technologies and processes that set Tanvex’s formulation development capabilities apart, including:
  • Innovative Platforms for Rapid, Accurate Development Faster, more accurate, and cost-effective biophysical and analytical screening platforms that are revolutionizing the approach to biopharmaceutical formulation
  • Interdisciplinary Expertise and Quality-by-Design The importance of a quality-by-design approach for elevating interactions between excipients and the drug substance to ensure the highest stability and patient-centric delivery methods
  • Harnessing the Power of AI and Machine Learning The potential of artificial intelligence and machine learning in predicting optimal formulations for biologic drugs.

Access the article

"*" indicates required fields

Name
Subscribe
This field is for validation purposes and should be left unchanged.